| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/14/2007 | CN1914149A Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events |
| 02/14/2007 | CN1913922A Vaginal compositions for treating infections |
| 02/14/2007 | CN1913896A Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
| 02/14/2007 | CN1913892A Medicinal compositions and combinations |
| 02/14/2007 | CN1913890A Compositions substantially free of galactomannan containing piperacillin and tazobactam |
| 02/14/2007 | CN1913887A Combination of voriconazole and an antifungal CYP2C19 inhibitor |
| 02/14/2007 | CN1913883A Combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD |
| 02/14/2007 | CN1913882A Treatment of rhinitis with anticholinergics alone or in combination with antihistamines, phosphodiesterase 4 inhibitors, or corticosteroids |
| 02/14/2007 | CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
| 02/14/2007 | CN1911913A New neuropeptide YY5 receptor antagonists |
| 02/14/2007 | CN1911450A Live target adjuvant containing D-galactose and sterol or aliphatic alcohol and its preparation |
| 02/14/2007 | CN1911245A Metal compunds, mixed or sulphated, as phosphate binders |
| 02/14/2007 | CN1911221A Use of a hypoglycemic agent for treating impaired glucose metabolism |
| 02/14/2007 | CN1300320C Alzhimer's disease secretase |
| 02/14/2007 | CN1299774C Slow released anticancer combination of medication embedded the interior of the body |
| 02/14/2007 | CN1299773C Anti-cancer medicine composition |
| 02/14/2007 | CN1299772C Anti-cancer medicine composition |
| 02/14/2007 | CN1299771C Colorstrum-based composition |
| 02/14/2007 | CN1299770C Multifunctional liquid for clean therapy of nasal cavity and sinuses |
| 02/14/2007 | CN1299690C Compositions for improving cardiovascular function |
| 02/14/2007 | CN1299689C Application of alendronate in preparation of drug for inhibitting bone resorption |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/14/2007 | CN1299667C Nano Chinese medicine threewingnut/Tripterygium prepn and its prepn process |
| 02/13/2007 | US7176283 Protease-activated receptor 3 and uses thereof |
| 02/13/2007 | US7176243 CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis |
| 02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 02/13/2007 | US7176198 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
| 02/13/2007 | US7176189 Methods for regeneration of a mammalian lens |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7176035 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
| 02/13/2007 | US7176020 Detection and monitoring anticarcinogenic agents; obtain tissue, infect with cancer cells, incubate with test compound, monitor antiproliferative activity |
| 02/13/2007 | US7175994 Lactacystin, a peptidyl aldehyde, or a peptidyl epoxy ketone inhibits proteasomal activity; epidermal growth factor, a fibroblast growth factor, a platelet-derived growth factor, a transforming growth factor, a parathyroid hormone, etc for promoting skin tissue growth, an excipient |
| 02/13/2007 | US7175859 aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor |
| 02/13/2007 | US7175854 Pharmaceutical preparation comprising an active dispersed on a matrix |
| 02/13/2007 | US7175842 Methods of modulating hair growth |
| 02/09/2007 | CA2618974A1 Nanoemulsion compositions having anti-inflammatory activity |
| 02/08/2007 | WO2007016108A1 Compositions for affecting weight loss |
| 02/08/2007 | WO2007015587A1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent |
| 02/08/2007 | WO2007015569A1 Method for prediction of the efficacy of vascularization inhibitor |
| 02/08/2007 | WO2007014943A2 Therapy for neurological diseases |
| 02/08/2007 | WO2007014872A1 Combination of itriglumide and proton pump inhibitors in the treatment of gastrointestinal and related disorders |
| 02/08/2007 | WO2006078422A3 Methods for modulating tumor growth and metastasis |
| 02/08/2007 | WO2006062732A3 Compounds acting at the centrosome |
| 02/08/2007 | WO2006048633A3 Combination comprising zd6474 and an antiandrogen |
| 02/08/2007 | WO2006042192A3 Relevance of achieved levels of markers of systemic inflammation following treatment |
| 02/08/2007 | WO2005122379A3 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 02/08/2007 | WO2005113006A3 Use of dipyridamole for treatment of resistance to platelet inhibitors |
| 02/08/2007 | WO2005070460A3 Combination therapy with 5-ht1a and 5-ht1b receptor antagonists |
| 02/08/2007 | WO2003059267A3 SELECTIVE 11β-HSD INHIBITORS AND METHODS FOR USE THEREOF |
| 02/08/2007 | US20070032642 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032538 Use of compounds |
| 02/08/2007 | US20070032537 5-Substituted 2h-pyrazole-3-carboxylic acid derivatives as agonists for the acid receptor rup25 for the treatment of dyslipidemia and related diseases |
| 02/08/2007 | US20070032471 Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator |
| 02/08/2007 | US20070032465 Pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha |
| 02/08/2007 | US20070032445 Antisense IAP nucleobase oligomers and uses thereof |
| 02/08/2007 | US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 02/08/2007 | US20070031979 Protein biopolymer markers predictive of type II diabetes |
| 02/08/2007 | US20070031929 Polypeptides Homologous To VEGF and BMP1 |
| 02/08/2007 | US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules |
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031513 Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 02/08/2007 | US20070031511 Method of treatment |
| 02/08/2007 | US20070031497 Gastric acid secretion inhibiting composition |
| 02/08/2007 | US20070031489 administering sub-analgesic dosage of a mu -opioid agonist selected from morphine, fentanyl, sufentanil, alfentanil, oxymorphone and hydromorphone, or salt, and a sub-analgesic dosage of oxycodone, a kappa 2-opioid agonist to prevent sleep apnea while treating pain |
| 02/08/2007 | US20070031462 Powder exfoliating compositions and methods for producing the same |
| 02/08/2007 | US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents |
| 02/08/2007 | US20070031434 Uses for Eph receptor antagonists and agonists |
| 02/08/2007 | US20070031413 Treatment with anti-vegf antibodies |
| 02/08/2007 | US20070031400 Dichloroacetate in combination with clinically high levels of cardioprotective or hemodynamic drugs |
| 02/08/2007 | US20070031398 One of several enzyme-containing compounds, dietetic food products and drugs produced from and the use therefor for medical purpose |
| 02/08/2007 | US20070031396 Method of treating neurological diseases |
| 02/08/2007 | CA2616941A1 Combination of itriglumide and proton pump inhibitors in the treatment of gastrointestinal and related disorders |
| 02/08/2007 | CA2614539A1 Compositions for affecting weight loss |
| 02/08/2007 | CA2613518A1 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators |
| 02/07/2007 | EP1749884A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 02/07/2007 | EP1749836A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/07/2007 | EP1749540A2 Compositions for improving bioavailability of orally administered drugs |
| 02/07/2007 | EP1749539A2 Preventives or remedies for fatty liver |
| 02/07/2007 | EP1749538A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor |
| 02/07/2007 | EP1749530A2 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods [1998/31] |
| 02/07/2007 | EP1749522A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 02/07/2007 | EP1748794A2 Sequential sprm/progestin treatment |
| 02/07/2007 | EP1748793A2 Estrogen modulation of ifn-gamma-mediated conditions and diseases |
| 02/07/2007 | EP1748781A1 Methods for treating bleeding disorders using sulfated polysaccharides |
| 02/07/2007 | EP1748772A2 Combination therapies for cancer and proliferative angiopathies |
| 02/07/2007 | EP1506211B1 C-aryl glucoside sglt2 inhibitors and method |
| 02/07/2007 | EP1503765A4 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| 02/07/2007 | EP1315501B1 Alpha v integrin receptor antagonists |
| 02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 02/07/2007 | EP0948646B1 Methods for identifying genes essential to the growth of an organism |
| 02/07/2007 | CN1909929A Anti-inflammatory analgesic for external use |
| 02/07/2007 | CN1909928A Complexes having adjuvant activity |
| 02/07/2007 | CN1909927A Method of suppressing cancer |
| 02/07/2007 | CN1909926A The use of cytokine able to bind IL-18BP and of inhibiting the activity of a second cytokine |
| 02/07/2007 | CN1909899A Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 02/07/2007 | CN1909892A Transdermal analgesic systems having reduced abuse potential |
| 02/07/2007 | CN1909780A Medium chain peroxycarboxylic acid compositions |
| 02/07/2007 | CN1907515A Five-element magnetotherapeutic health caring belt |
| 02/07/2007 | CN1907265A Self-micro-emulsifying composition comprising amphipathic polymer and process for its preparation |